A very good quarterly and the 4th showing gradual improvements and more granular comments
on customers. Receivables plus inventories provide an extra buffer to the cash position and 'recurring sales' is a greet validation regarding their consumable customers.
Key is that many customers have multiple sites and
labs so we could see higher orders from the same customers over the coming quarters. We shall see.
Best quarter they ever had as far as I can remember. Meanwhile thee share price remains stick to where it was 2 years ago during the end of the labcon agreement (which for the business was the right thing as we see now.).
- Forums
- ASX - By Stock
- BCT
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.616M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BCT (ASX) Chart |
Day chart unavailable